← FDA Drug Approvals (Drugs@FDA)

METHYLPREDNISOLONE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2018-06-27

Drug application

FDA Application #

ANDA201835

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLPREDNISOLONE ACETATE

Generic name

METHYLPREDNISOLONE ACETATE

Active ingredients

METHYLPREDNISOLONE ACETATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2018-06-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown